4//SEC Filing
McCombe William D. 4
Accession 0001415889-25-007282
CIK 0001831915other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:56 PM ET
Size
8.4 KB
Accession
0001415889-25-007282
Insider Transaction Report
Form 4
McCombe William D.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-04+330,882→ 330,882 totalExercise: $4.31Exp: 2035-03-04→ Common Stock (330,882 underlying) - Award
Restricted Stock Units
2025-03-04+208,816→ 208,816 total→ Common Stock (208,816 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest over 4 years with 1/48 of the total shares underlying the option vesting on April 4, 2025 and each month thereafter until fully vested.
- [F2]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested.
Documents
Issuer
Cytek Biosciences, Inc.
CIK 0001831915
Entity typeother
Related Parties
1- filerCIK 0001878824
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:56 PM ET
- Size
- 8.4 KB